Wegovy (semaglutide) is often a medication authorised from the Food and Drug Administration (FDA) in 2021 that can help individuals reduce weight loss and preserve weight loss. It’s intended for Older people with a entire body mass index (BMI) of 30 or even more or even a BMI or 27 or even more who may have a weight-relevant health care dilemma.